Glaukos Corporation
GKOS
Rankning i aktier
#2026
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Aktiekurs
$174.03
Senast synkroniserad: 2026-10-20
Marknadsvärde
$10.26B
Förändring (1 dag)
4.34%
Förändring (1 år)
129.35%
Land
US
Handel Glaukos Corporation (GKOS)
Kategori
Healthcare
Historik för aktiesplit för Glaukos Corporation (GKOS)
Aktien Glaukos Corporation (symbol: GKOS) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En GKOS-aktie köpt före Oct 21, 2026 motsvarar nu 0 GKOS-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En GKOS-aktie köpt före Oct 21, 2026 motsvarar nu 0 GKOS-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 2 | x4 |
US
|
|
| 0 | - |
DE
|
